Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 43, 2008 - Issue 9
Submit an article Journal homepage
186
Views
56
CrossRef citations to date
0
Altmetric
Original Article

Serum adipokine levels in chronic liver diseases: Association of resistin levels with fibrosis severity

Emmanuel Tsochatzis Second Department of Internal Medicine, Athens University Medical School, Hippokration General Hospital, Athens, Greece
,
George V. Papatheodoridis Second Department of Internal Medicine, Athens University Medical School, Hippokration General Hospital, Athens, GreeceCorrespondence[email protected]
, MD,
Emilia Hadziyannis Second Department of Internal Medicine, Athens University Medical School, Hippokration General Hospital, Athens, Greece
,
Anastasia Georgiou Second Department of Internal Medicine, Athens University Medical School, Hippokration General Hospital, Athens, Greece
,
Georgia Kafiri Department of Pathology, Hippokration General Hospital, Athens, Greece
,
Dina G. Tiniakos Laboratory of Histology & Embryology, Athens University Medical School, Greece
,
Emanuel K. Manesis Second Department of Internal Medicine, Athens University Medical School, Hippokration General Hospital, Athens, Greece
&
Athanasios J. Archimandritis Second Department of Internal Medicine, Athens University Medical School, Hippokration General Hospital, Athens, Greece
 show all
Pages 1128-1136 | Received 10 Dec 2007, Published online: 08 Jul 2009

Citations (56)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Vincent Kaddai & Francesco Negro. (2011) Current understanding of insulin resistance in hepatitis C. Expert Review of Gastroenterology & Hepatology 5:4, pages 503-516.
Read now
Lars Aabakken. (2008) This month in Scandinavian Journal of Gastroenterology. Scandinavian Journal of Gastroenterology 43:9, pages 1027-1029.
Read now

Articles from other publishers (54)

Seidamir Pasha TABAEIAN, Touraj MAHMOUDI, Gholamreza REZAMAND, Hossein NOBAKHT, Reza DABIRI, Hamid FARAHANI, Asadollah ASADI & Mohammad Reza ZALI. (2022) RESISTIN GENE POLYMORPHISM AND NONALCOHOLIC FATTY LIVER DISEASE RISK. Arquivos de Gastroenterologia 59:4, pages 483-487.
Crossref
Christina Tontikidou, Evangelia S Makri, Kleo Evripidou, Dimitrios G Goulis, Antonis Goulas & Stergios A Polyzos. (2022) Circulating adiponectin in patients with nonalcoholic fatty liver disease‐related liver fibrosis: A systematic review and a meta‐analysis. Journal of Gastroenterology and Hepatology 37:10, pages 1853-1864.
Crossref
Simona Alexandra Iacob & Diana Gabriela Iacob. (2022) Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients – a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis Breakdown. Frontiers in Endocrinology 13.
Crossref
Nerma Čustović & Senija Rašić. (2022) Relationship of serum adiponectin and resistin levels with the severity of liver fibrosis in patients with chronic hepatitis B. Journal of Medical Biochemistry 41:2, pages 176-183.
Crossref
Revathy Carnagarin, Marcio G. Kiuchi, Gerard Goh, Leon Adams, Neale Cohen, Helen Kavnoudias, Seng K. Gan, Greg Van Schie, Murray D. Esler, Vance B. Matthews & Markus P. Schlaich. (2021) Role of the sympathetic nervous system in cardiometabolic control: implications for targeted multiorgan neuromodulation approaches. Journal of Hypertension 39:8, pages 1478-1489.
Crossref
Arunraj Namachivayam & Abilash Valsala Gopalakrishnan. (2021) A review on molecular mechanism of alcoholic liver disease. Life Sciences 274, pages 119328.
Crossref
Dongli Han, Jie Chen, Shousheng Liu, Zengzhi Zhang, Zhenzhen Zhao, Wenwen Jin & Yongning Xin. (2021) Serum Resistin Levels in Adult Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis. Journal of Clinical and Translational Hepatology 000:000, pages 000-000.
Crossref
Revathy Carnagarin, Kearney Tan, Leon Adams, Vance B. Matthews, Marcio G. Kiuchi, Leslie Marisol Lugo Gavidia, Gavin W. Lambert, Elisabeth A. Lambert, Lakshini Y. Herat & Markus P. Schlaich. (2021) Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—A Condition Associated with Heightened Sympathetic Activation. International Journal of Molecular Sciences 22:8, pages 4241.
Crossref
Xiaoyan Wu, Elise R. den Boer, Manon Vos-Loohuis, Frank G. van Steenbeek, Glen R. Monroe, Isaäc J. Nijman, Peter. A. J. Leegwater & Hille Fieten. (2020) Investigation of Genetic Modifiers of Copper Toxicosis in Labrador Retrievers. Life 10:11, pages 266.
Crossref
Hyeki Cho, Young Chang, Jeong-Hoon Lee, Young Youn Cho, Joon Yeul Nam, Yun Bin Lee, Dong Ho Lee, Eun Ju Cho, Su Jong Yu, Yoon Jun Kim, Jeong Min Lee & Jung-Hwan Yoon. (2020) Radiologic Nonalcoholic Fatty Liver Disease Increases the Risk of Hepatocellular Carcinoma in Patients With Suppressed Chronic Hepatitis B. Journal of Clinical Gastroenterology 54:7, pages 633-641.
Crossref
Chia-Chi Wang, Pin-Nan Cheng & Jia-Horng Kao. (2020) Systematic review: chronic viral hepatitis and metabolic derangement. Alimentary Pharmacology & Therapeutics 51:2, pages 216-230.
Crossref
Bei Liu. (2020) Levels and Significance of Serum Adiponectin in Patients with Chronic HBV Infection at Different Clinical Stages. E3S Web of Conferences 185, pages 03008.
Crossref
Seyyed Mortaza Haghgoo, Heidar Sharafi & Seyed Moayed Alavian. (2019) Serum cytokines, adipokines and ferritin for non-invasive assessment of liver fibrosis in chronic liver disease: a systematic review. Clinical Chemistry and Laboratory Medicine (CCLM) 57:5, pages 577-610.
Crossref
E. Acquarone, F. Monacelli, R. Borghi, A. Nencioni & P. Odetti. (2019) Resistin: A reappraisal. Mechanisms of Ageing and Development 178, pages 46-63.
Crossref
Anna Alisi, Valerio Nobili & Melania Manco. 2019. Global Perspectives on Childhood Obesity. Global Perspectives on Childhood Obesity 209 222 .
Inas El Khedr Mohamed, Hany Samir Rasmy & Wagih Abd Elwahab Aly. (2018) Evaluation of serum resistin levels in patients with hepatocellular carcinoma before and after treatment. Egyptian Liver Journal 8:2, pages 61-67.
Crossref
Telma Erotides da Silva, Mariana Costa-Silva, Carina G. Correa, Giovana Denardin, Maria L. Ayres Alencar, Mara S. Pacheco Honório Coelho, Letícia Muraro-Wildner, Maria Luiza-Bazzo, David A. González-Chica, Esther Buzaglo Dantas-Correa, Janaína L. Narciso-Schiavon & Leonardo de Lucca Schiavon. (2018) Clinical Significance of Serum Adiponectin and Resistin Levels in Liver Cirrhosis. Annals of Hepatology 17:2, pages 286-299.
Crossref
Xu Zhang, Xuetao Ji, Qian Wang & John Zhong Li. (2017) New insight into inter-organ crosstalk contributing to the pathogenesis of non-alcoholic fatty liver disease (NAFLD). Protein & Cell 9:2, pages 164-177.
Crossref
Mariana Verdelho Machado & Anna Mae Diehl. 2018. Zakim and Boyer's Hepatology. Zakim and Boyer's Hepatology 369 390.e14 .
Zhongji Meng, Yonghong Zhang, Zhiqiang Wei, Ping Liu, Jian Kang, Yinhua Zhang, Deqiang Ma, Changzheng Ke, Yue Chen, Jie Luo & Zuojiong Gong. (2017) High serum resistin associates with intrahepatic inflammation and necrosis: an index of disease severity for patients with chronic HBV infection. BMC Gastroenterology 17:1.
Crossref
Rafael Bergesch D’Incao, Cristiane Valle Tovo, Vanessa Suñé Mattevi, Diego Olschowsky Borges, Jane Maria Ulbrich, Gabriela Perdomo Coral, Mauricio Jacques Ramos & Nelson Guardiola Meinhardt. (2017) Adipokine Levels Versus Hepatic Histopathology in Bariatric Surgery Patients. Obesity Surgery 27:8, pages 2151-2158.
Crossref
Otto K.-W. Cheung & Alfred S.-L. Cheng. (2016) Gender Differences in Adipocyte Metabolism and Liver Cancer Progression. Frontiers in Genetics 7.
Crossref
Elena Buzzetti, Massimo Pinzani & Emmanuel A. Tsochatzis. (2016) The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism 65:8, pages 1038-1048.
Crossref
Natasha McDonald & Jonathan Fallowfield. 2016. Clinical Dilemmas in Non‐Alcoholic Fatty Liver Disease. Clinical Dilemmas in Non‐Alcoholic Fatty Liver Disease 218 225 .
Silvia M. Ferolla. 2016. Obesity. Obesity 159 179 .
Francesco Negro, Daniel Forton, Antonio Craxì, Mark S. Sulkowski, Jordan J. Feld & Michael P. Manns. (2015) Extrahepatic Morbidity and Mortality of Chronic Hepatitis C. Gastroenterology 149:6, pages 1345-1360.
Crossref
Joanna Olszok, Anna Wyganowska, Joanna Tarabura-Dragon, Franciszek Mazur & Mariusz Nowak. (2015) Selected adipocytokines and their potential role in the control of the course of chronic hepatitis B and C. Annales Academiae Medicae Silesiensis 69, pages 1-7.
Crossref
Jamie E. Mells, Ping P. Fu, Pradeep Kumar, Tekla Smith, Saul J. Karpen & Frank A. Anania. (2015) Saturated fat and cholesterol are critical to inducing murine metabolic syndrome with robust nonalcoholic steatohepatitis. The Journal of Nutritional Biochemistry 26:3, pages 285-292.
Crossref
Laura Marino. (2015) Endocrine causes of nonalcoholic fatty liver disease. World Journal of Gastroenterology 21:39, pages 11053.
Crossref
Maria Kalafateli. (2015) Adipokines levels are associated with the severity of liver disease in patients with alcoholic cirrhosis. World Journal of Gastroenterology 21:10, pages 3020.
Crossref
Stergios A. Polyzos, Jannis Kountouras & Christos S. Mantzoros. (2015) Leptin in nonalcoholic fatty liver disease: A narrative review. Metabolism 64:1, pages 60-78.
Crossref
Pilar Codoñer-Franch & Eulalia Alonso-Iglesias. (2015) Resistin: Insulin resistance to malignancy. Clinica Chimica Acta 438, pages 46-54.
Crossref
Chuan Shen, Cai-Yan Zhao, Wei Wang, Ya-Dong Wang, Hui Sun, Wei Cao, Wei-Yan Yu, Li Zhang, Ru Ji, Meng Li & Jian Gao. (2014) The relationship between hepatic resistin overexpression and inflammation in patients with nonalcoholic steatohepatitis. BMC Gastroenterology 14:1.
Crossref
Kumiko Mera, Hirofumi Uto, Seiichi Mawatari, Akio Ido, Yozo Yoshimine, Tsuyoshi Nosaki, Kohei Oda, Kazuaki Tabu, Kotaro Kumagai, Tsutomu Tamai, Akihiro Moriuchi, Makoto Oketani, Yuko Shimada, Masaaki Hidaka, Susumu Eguchi & Hirohito Tsubouchi. (2014) Serum levels of apoptosis inhibitor of macrophage are associated with hepatic fibrosis in patients with chronic hepatitis C. BMC Gastroenterology 14:1.
Crossref
T.E. Silva, G. Colombo & L.L. Schiavon. (2014) Adiponectin: A multitasking player in the field of liver diseases. Diabetes & Metabolism 40:2, pages 95-107.
Crossref
Sanja Stojsavljević. (2014) Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease. World Journal of Gastroenterology 20:48, pages 18070.
Crossref
Xiao-Min Xin. (2014) GW4064, a farnesoid X receptor agonist, upregulates adipokine expression in preadipocytes and HepG2 cells. World Journal of Gastroenterology 20:42, pages 15727.
Crossref
Sheau-Fang Yang, Chien-Wei Chang, Ren-Jie Wei, Yow-Ling Shiue, Shen-Nien Wang & Yao-Tsung Yeh. (2014) Involvement of DNA Damage Response Pathways in Hepatocellular Carcinoma. BioMed Research International 2014, pages 1-18.
Crossref
Ancha Baranova, Aybike Birerdinc & Zobair M. Younossi. 2014. Adipose Tissue and Adipokines in Health and Disease. Adipose Tissue and Adipokines in Health and Disease 249 283 .
Jun Zhao & Matthew W. Lawless. (2013) Stop feeding cancer: Pro-inflammatory role of visceral adiposity in liver cancer. Cytokine 64:3, pages 626-637.
Crossref
Xiao-Feng Duan, Peng Tang, Qiang Li & Zhen-Tao Yu. (2013) Obesity, adipokines and hepatocellular carcinoma. International Journal of Cancer 133:8, pages 1776-1783.
Crossref
Harry Yoon, Jeong Guil Lee, Jeong Hwan Yoo, Myung Su Son, Dae Young Kim, Seong Gyu Hwang & Kyu Sung Rim. (2013) Effects of Metabolic Syndrome on Fibrosis in Chronic Viral Hepatitis. Gut and Liver 7:4, pages 469-474.
Crossref
Rocio AllerDaniel de LuisDavid PachecoMaria Concepcion VelascoOlatz IzaolaManuel Gonzalez Sagrado. (2023) Insulin Resistance Predicts Steatosis and Fibrosis in Morbidly Obese Patients Undergoing Bariatric Surgery. Journal of Investigative Medicine 60:7, pages 1005-1008.
Crossref
W. Chen, G. Tomlinson, M. Krahn & J. Heathcote. (2012) Immigrant patients with chronic hepatitis C and advanced fibrosis have a higher risk of hepatocellular carcinoma. Journal of Viral Hepatitis 19:8, pages 574-580.
Crossref
Christopher Sjöwall, Kristina Cardell, Elisabeth A. Boström, Maria I. Bokarewa, Helena Enocsson, Mattias Ekstedt, Liselott Lindvall, Aril Frydén & Sven Almer. (2012) High prevalence of autoantibodies to C-reactive protein in patients with chronic hepatitis C infection: association with liver fibrosis and portal inflammation. Human Immunology 73:4, pages 382-388.
Crossref
Stergios A. Polyzos, Jannis Kountouras, Christos Zavos & Georgia Deretzi. (2011) The Potential Adverse Role of Leptin Resistance in Nonalcoholic Fatty Liver Disease. Journal of Clinical Gastroenterology 45:1, pages 50-54.
Crossref
Valerio Nobili, Anna Alisi & Melania Manco. 2011. Global Perspectives on Childhood Obesity. Global Perspectives on Childhood Obesity 221 230 .
Francesco Negro & Sophie Clément. 2010. Signaling Pathways in Liver Diseases. Signaling Pathways in Liver Diseases 483 491 .
Anna Alisi, Melania Manco, Rita Devito & Valerio Nobili. 2010. Pediatric Obesity. Pediatric Obesity 201 222 .
Marianna Argentou, Dina G. Tiniakos, Menelaos Karanikolas, Maria Melachrinou, Maria G. Makri, Christos Kittas & Fotis Kalfarentzos. (2009) Adipokine Serum Levels Are Related to Liver Histology in Severely Obese Patients Undergoing Bariatric Surgery. Obesity Surgery 19:9, pages 1313-1323.
Crossref
Fabio Marra & Cristiana Bertolani. (2009) Adipokines in liver diseases. Hepatology 50:3, pages 957-969.
Crossref
Arzu Tiftikci, Ozlen Atug, Yusuf Yilmaz, Fatih Eren, Filiz Ture Ozdemir, Suna Yapali, Osman Ozdogan, Cigdem Ataizi Celikel, Nese Imeryuz & Nurdan Tozun. (2009) Serum Levels of Adipokines in Patients with Chronic HCV Infection: Relationship with Steatosis and Fibrosis. Archives of Medical Research 40:4, pages 294-298.
Crossref
Francesco Negro & Mahnaz Alaei. (2009) Hepatitis C virus and type 2 diabetes. World Journal of Gastroenterology 15:13, pages 1537.
Crossref
Emmanuel A. Tsochatzis, George V. Papatheodoridis & Athanasios J. Archimandritis. (2009) Adipokines in Nonalcoholic Steatohepatitis: From Pathogenesis to Implications in Diagnosis and Therapy. Mediators of Inflammation 2009, pages 1-8.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.